Hana Must SPAC 2 (208370) - Total Liabilities
Based on the latest financial reports, Hana Must SPAC 2 (208370) has total liabilities worth ₩6.87 Billion KRW (≈ $4.66 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 208370 cash flow metrics to assess how effectively this company generates cash.
Hana Must SPAC 2 - Total Liabilities Trend (2015–2024)
This chart illustrates how Hana Must SPAC 2's total liabilities have evolved over time, based on quarterly financial data. Check Hana Must SPAC 2 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Hana Must SPAC 2 Competitors by Total Liabilities
The table below lists competitors of Hana Must SPAC 2 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hwacheon Machi
KO:010660
|
Korea | ₩45.75 Billion |
|
Vinyl Group Ltd
AU:VNL
|
Australia | AU$5.15 Million |
|
Danang Rubber JSC
VN:DRC
|
Vietnam | ₫2.23 Trillion |
|
Ak Holdings
KO:006840
|
Korea | ₩4.52 Trillion |
|
QPM Energy Ltd
AU:QPM
|
Australia | AU$170.18 Million |
|
Billion Electric Co Ltd
TW:3027
|
Taiwan | NT$552.80 Million |
|
Inovio Pharmaceuticals Inc
NASDAQ:INO
|
USA | $77.11 Million |
|
United Polyfab Gujarat Limited
NSE:UNITEDPOLY
|
India | Rs1.49 Billion |
Liability Composition Analysis (2015–2024)
This chart breaks down Hana Must SPAC 2's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Hana Must SPAC 2 market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.12 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hana Must SPAC 2's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hana Must SPAC 2 (2015–2024)
The table below shows the annual total liabilities of Hana Must SPAC 2 from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩6.42 Billion ≈ $4.35 Million |
-2.44% |
| 2023-12-31 | ₩6.58 Billion ≈ $4.46 Million |
-46.09% |
| 2022-12-31 | ₩12.21 Billion ≈ $8.28 Million |
-41.63% |
| 2021-12-31 | ₩20.92 Billion ≈ $14.18 Million |
+3.36% |
| 2020-12-31 | ₩20.24 Billion ≈ $13.72 Million |
-11.87% |
| 2019-12-31 | ₩22.97 Billion ≈ $15.57 Million |
-13.82% |
| 2018-12-31 | ₩26.65 Billion ≈ $18.06 Million |
-0.85% |
| 2017-12-31 | ₩26.88 Billion ≈ $18.22 Million |
+44.79% |
| 2016-12-31 | ₩18.57 Billion ≈ $12.58 Million |
-34.07% |
| 2015-12-31 | ₩28.16 Billion ≈ $19.08 Million |
-- |
About Hana Must SPAC 2
SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The compa… Read more